LEADERSHIP

Lara Longpre joined Mirum in 2018 as Chief Development Officer with responsibility for program leadership, regulatory affairs, clinical operations, and biometrics.  She brings more than 29 years of experience in the biopharmaceutical industry developing innovative and complex therapies.

Prior to Mirum, she served as chief operating officer at MedGenesis Therapeutix and Jennerex Biotherapeutics where she held responsibilities for program management, alliance management, clinical operations, technical operations, regulatory affairs, and quality assurance. She previously held several leadership roles in Contract Research Organizations including PRA International and CroMedica International where had responsibility for clinical operations and project management, global regulatory affairs, and proposals & contracts.

Lara received a Master of Medical Science degree from Harvard Medical School, an M.B.A. from Queen’s University in Ontario, Canada, and her undergraduate degree in biology from Cornell University.